9:00 – 9:05 AM

Welcome

Jeffrey Shuren; Assistant Commissioner for Policy, FDA

9:05 – 9:15 AM

Opening Remarks

Janet Woodcock; Deputy Commissioner, Chief Medical Officer, FDA

9:15 – 9:20AM

Meeting Format

Jeffrey Shuren

Presentations by Registered Speakers

9:20 – 9:45 AM

Mr. D. Bruce Cohen; Technical Director, Unit Operations; GlaxoSmithKline (representing PhRMA)

9:45 – 10:10 AM

Mr. Peter Mayberry; Executive Director;Pharmaceutical Printed Literature Association

10:10 – 10:30 AM

Dr. Thomas F. Willer; Director, Global Regulatory Affairs, Hospira

10:30 – 10:50 AM

Mrs. Vera Sharav; President, Alliance for Human Research Protection

10:50 – 11:05 AM

Break

11:05 – 11:30 AM

Mr. John Coster; Vice President, Policy and Programs, NACDS

11:30 – 11:40 AM

Mr. Douglas J. Scheckelhoff; Director, Pharmacy Practice Managers , American Society of Health-System Pharmacists

11:40 AM – 12:00 PM

Dr. Danielle Daignault; Managing Editor, Alchemy DSMs, Gold Standard Inc., An Elsevier Company

12:00 – 1:20 PM

 Lunch (on own)

1:20 – 1:45 PM

Dr. Mukesh Mehta; Vice President, Thomson Healthcare

1:45 – 2:10 PM

Ms. Karen Kistler; Genentech, Inc. 

2:10 – 2:30 PM

Ms. Anita Ducca; Sr. Director, Regulatory Affairs & Healthcare Policy, Healthcare Distribution Management Association

2:30 – 3:25 PM

Open Public Session Break

3:25 – 3:30 PM

 Closing Remarks

 Jeffrey Shuren

3:30 PM

 Meeting Adjourned